Autonomous proliferation and bcl-2 expression involving haematopoietic cells in patients with myelodysplastic syndrome
1998

Proliferation and bcl-2 Expression in Myelodysplastic Syndrome Patients

Sample size: 15 publication Evidence: moderate

Author Information

Author(s): C Bincoletto, STO Saad, E Soares da Silva, MLS Queiroz

Primary Institution: State University of Campinas, Faculty of Medical Sciences, Unicamp, Brazil

Hypothesis

Is there a relationship between autonomous proliferation, bcl-2 expression, and apoptosis in myelodysplastic syndrome patients?

Conclusion

The study found that myelodysplastic syndrome patients have higher levels of cell proliferation but lower bcl-2 expression, leading to increased cell death.

Supporting Evidence

  • Autonomous proliferation was significantly greater in MDS patients than in control subjects.
  • Bcl-2 expression was significantly lower in MDS patients compared to normal individuals.
  • The percentage of apoptotic cells was significantly increased in MDS bone marrow cells compared to control subjects.

Takeaway

Patients with a certain blood disorder grow more cells, but many of them die because they don't have enough of a protein that helps keep cells alive.

Methodology

The study evaluated bcl-2 expression, autonomous colony formation, and apoptosis in bone marrow cells from MDS patients and compared them to normal controls.

Limitations

The study could not correlate bcl-2 expression with apoptosis due to advanced stages of cell death in most samples.

Participant Demographics

Patients diagnosed with myelodysplastic syndromes, primarily elderly individuals.

Statistical Information

P-Value

P = 0.001 for proliferation, P = 0.002 for bcl-2 expression, P = 0.001 for apoptosis

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication